| Specialty Retail Industry | Consumer Discretionary Sector | Rong Hua Wang CEO | OTC PINK Exchange | 090678301 CUSIP |
| CN Country | 200 Employees | - Last Dividend | 4 Apr 2012 Last Split | - IPO Date |
Biostar Pharmaceuticals, Inc. is a notable entity in the pharmaceutical industry, focusing on the development, manufacture, and marketing of both over-the-counter (OTC) and prescription pharmaceutical products. The company directs its efforts towards addressing various diseases and conditions predominantly in the People's Republic of China. Since its inception in 2007 and being headquartered in Xianyang, Biostar Pharmaceuticals has carved a niche in the Chinese healthcare market. It is especially recognized for its OTC medicine—Xin Ao Xing Oleanolic Acid capsule, widely used for chronic hepatitis B. Moreover, its strategic utilization of an online platform, serving as an Internet-based China Hepatitis Internet hospital, underscores its commitment to innovating the delivery of healthcare information and services. Through a comprehensive distribution network and a diligent sales force, the company ensures its presence across approximately 28 provinces in China.
Biostar Pharmaceuticals' product line is diversified across OTC items and prescription-based medications, catering to a wide spectrum of healthcare needs.